Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation

NCT03423706 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT03423706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03423706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation
Lead sponsor
First Affiliated Hospital of Harbin Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
May 7, 2018
Completion date
December 31, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cd19-chimeric antigen receptor t cells, relapsed and/or refractory acute lymphoblastic leukemia, the haploidentical hematopoietic stem cell transplantation